IBDEI2HM ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,42187,1,4,0)
 ;;=4^R94.4
 ;;^UTILITY(U,$J,358.3,42187,2)
 ;;=^5019741
 ;;^UTILITY(U,$J,358.3,42188,0)
 ;;=R94.5^^159^2016^17
 ;;^UTILITY(U,$J,358.3,42188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42188,1,3,0)
 ;;=3^Abnormal Liver Function Studies
 ;;^UTILITY(U,$J,358.3,42188,1,4,0)
 ;;=4^R94.5
 ;;^UTILITY(U,$J,358.3,42188,2)
 ;;=^5019742
 ;;^UTILITY(U,$J,358.3,42189,0)
 ;;=R94.6^^159^2016^21
 ;;^UTILITY(U,$J,358.3,42189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42189,1,3,0)
 ;;=3^Abnormal Thyroid Function Studies
 ;;^UTILITY(U,$J,358.3,42189,1,4,0)
 ;;=4^R94.6
 ;;^UTILITY(U,$J,358.3,42189,2)
 ;;=^5019743
 ;;^UTILITY(U,$J,358.3,42190,0)
 ;;=R94.7^^159^2016^5
 ;;^UTILITY(U,$J,358.3,42190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42190,1,3,0)
 ;;=3^Abnormal Endocrine Function Sutdies NEC
 ;;^UTILITY(U,$J,358.3,42190,1,4,0)
 ;;=4^R94.7
 ;;^UTILITY(U,$J,358.3,42190,2)
 ;;=^5019744
 ;;^UTILITY(U,$J,358.3,42191,0)
 ;;=R94.31^^159^2016^4
 ;;^UTILITY(U,$J,358.3,42191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42191,1,3,0)
 ;;=3^Abnormal EKG
 ;;^UTILITY(U,$J,358.3,42191,1,4,0)
 ;;=4^R94.31
 ;;^UTILITY(U,$J,358.3,42191,2)
 ;;=^5019739
 ;;^UTILITY(U,$J,358.3,42192,0)
 ;;=R97.0^^159^2016^67
 ;;^UTILITY(U,$J,358.3,42192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42192,1,3,0)
 ;;=3^Elevated Carcinoembryonic Antigen 
 ;;^UTILITY(U,$J,358.3,42192,1,4,0)
 ;;=4^R97.0
 ;;^UTILITY(U,$J,358.3,42192,2)
 ;;=^5019746
 ;;^UTILITY(U,$J,358.3,42193,0)
 ;;=R97.1^^159^2016^66
 ;;^UTILITY(U,$J,358.3,42193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42193,1,3,0)
 ;;=3^Elevated Cancer Antigen 125
 ;;^UTILITY(U,$J,358.3,42193,1,4,0)
 ;;=4^R97.1
 ;;^UTILITY(U,$J,358.3,42193,2)
 ;;=^5019747
 ;;^UTILITY(U,$J,358.3,42194,0)
 ;;=R97.2^^159^2016^68
 ;;^UTILITY(U,$J,358.3,42194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42194,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,42194,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,42194,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,42195,0)
 ;;=R97.8^^159^2016^22
 ;;^UTILITY(U,$J,358.3,42195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42195,1,3,0)
 ;;=3^Abnormal Tumor Markers NEC
 ;;^UTILITY(U,$J,358.3,42195,1,4,0)
 ;;=4^R97.8
 ;;^UTILITY(U,$J,358.3,42195,2)
 ;;=^5019749
 ;;^UTILITY(U,$J,358.3,42196,0)
 ;;=R93.8^^159^2016^12
 ;;^UTILITY(U,$J,358.3,42196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42196,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Body Structures
 ;;^UTILITY(U,$J,358.3,42196,1,4,0)
 ;;=4^R93.8
 ;;^UTILITY(U,$J,358.3,42196,2)
 ;;=^5019721
 ;;^UTILITY(U,$J,358.3,42197,0)
 ;;=R93.1^^159^2016^14
 ;;^UTILITY(U,$J,358.3,42197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42197,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Heart/Cor Circ
 ;;^UTILITY(U,$J,358.3,42197,1,4,0)
 ;;=4^R93.1
 ;;^UTILITY(U,$J,358.3,42197,2)
 ;;=^5019714
 ;;^UTILITY(U,$J,358.3,42198,0)
 ;;=R68.83^^159^2016^48
 ;;^UTILITY(U,$J,358.3,42198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42198,1,3,0)
 ;;=3^Chills w/o Fever
 ;;^UTILITY(U,$J,358.3,42198,1,4,0)
 ;;=4^R68.83
 ;;^UTILITY(U,$J,358.3,42198,2)
 ;;=^5019555
 ;;^UTILITY(U,$J,358.3,42199,0)
 ;;=R68.2^^159^2016^62
 ;;^UTILITY(U,$J,358.3,42199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42199,1,3,0)
 ;;=3^Dry Mouth,Unspec
 ;;^UTILITY(U,$J,358.3,42199,1,4,0)
 ;;=4^R68.2
 ;;^UTILITY(U,$J,358.3,42199,2)
 ;;=^5019552
 ;;^UTILITY(U,$J,358.3,42200,0)
 ;;=R09.02^^159^2016^88
 ;;^UTILITY(U,$J,358.3,42200,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,42200,1,3,0)
 ;;=3^Hypoxemia
 ;;^UTILITY(U,$J,358.3,42200,1,4,0)
 ;;=4^R09.02
 ;;^UTILITY(U,$J,358.3,42200,2)
 ;;=^332831
